U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07066267) titled 'Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT)' on July 04.
Brief Summary: The purpose of this study is to investigate the potential of autologous adipose stem cell (ASC) mitochondrial transfer (ASCENT) to oocytes along with intracytoplasmic sperm injection (ICSI)as a means of enhancing embryo development and improving the success rate of in patients with a history of multiple IVF failures. Embryo quality plays a crucial role in determining the success of assisted reproductive technologies and directly contributes to repeated pregnancy failures. Several factors, including age, physiological conditions, genetics, ...